Pilot Grant Program

We fund innovative, high-potential pilot studies that could significantly advance the field. Since the Foundation’s inception this program has funded many novel ideas for the diagnosis and treatment of prostate cancer and has provided support for operating expenses. 

The pilot grant program is specifically designed to complement, rather than compete with, funding from traditional sources such as the CCSRI (formerly National Cancer Institute of Canada) and CIHR. The Foundation has developed a fully webified fast-track application process designed to minimize paperwork and accelerate funding to prostate cancer researchers. The funds are released within 90 days of the close of competition.

Through the pilot grant program, the Foundation grants over $1 million each year to physicians, researchers and scientists from all across Canada, many of whom are first-time grantees. Often, because the Foundation tends to fund early-stage projects, the awards are the only source of funding for these projects. 

 
Learn more about the specific funded projects by year. 

To read an interesting article on how Aaron Bacher, member of PCCN Toronto learnt who gets research dollars and how it is decided click here.

To learn more about the Clinician Scientist Award Program click here
 
 
2012 Request for Applications: Pilot Grant Program
 
1. Program Objective
This Request for Applications (RFA) is intended to support biological and clinical research projects that are Prostate Cancer specific/exclusive in nature.
 
2. Mechanisms of Support
NEW: This year the value of the Pilot Grant has been increased to a maximum value of $150,000 over 2.5 years
 
3. Program Eligibility
In order to apply for this award, applicants must:
Hold a faculty position with a Canadian university, teaching hospital or cancer care institution
NEW: This year PCC will be reviewing Established Investigators (those with more than 8 years of research experience within a faculty position) separately from New Investigators (those with up to 8 years of experience within a faculty position)
 
4. Applications
To apply, applicants must fill out an online application form which will be found on the Prostate Cancer Canada website - application -  on January 3, 2012.

5. Important Dates          

Competition Opens               January 3, 2012
Applications Deadline            March 30, 2012 at 5p.m. EST
Notice of Decision                 June 29, 2012
Funding Start Date                July 3, 2012

 

6. Contact

Joanne Reynolds, Manager Grants & Awards
Prostate Cancer Canada 
2 Lombard Street, 3rd Floor
Toronto, Ontario, M5C 1M1
416-441-2131 Ext. 226
1-888-255-0333
joanne.reynolds@prostatecancer.ca

 

 



Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
New test developed to detect men at high risk of prostate cancer recurrence

Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More

CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be

Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More

$1.8 Million awarded to Movember Rising Stars Supporting Innovators in Prostate Cancer Research

Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More

Support for Those Affected by Prostate Cancer

Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More


Click here for news archive